COVID-19 vaccines shortage dragged markets lower - Thursday Review, January 28

COVID-19 vaccines shortage dragged markets lower - Thursday Review, January 28

European shares reached one-month low amid pandemic-related issues

The US

Stocks ended in the green, driven by the latest economic readings that point to a steady recovery. Also, the number of unemployment claims came in lower-than-expected. USA30 rose 0.99%, while USA500 added 0.91%. TECH100 gained 0.50%.

Crude oil traded 0.7% lower at $52.50 a barrel.

Gold fell 0.4% to $1,837.60 per ounce.

Asia and Australia

The markets were down after some of the largest companies, such as Tesla, Starbucks, and Boeing, reported disappointing quarterly earnings. Japan225 was down 1.21%.

HongKong45 fell 2.23%.

Down under, Australia200 lost 2.10%.

Europe

The mood on the markets was affected by the slow rollout of COVID-19 vaccines. Moreover, various countries are preparing new entry restrictions for travelers from certain parts of the world. Europe50 fell 1.9%, and Germany30 lost 1.7%. France40 and UK100 closed 0.9% and 1.4% lower, respectively.

Brent oil fell 0.6% to %55.20 per barrel.

EUR/USD traded at 1.2102 after it lost 0.1%.

Read here about the latest US unemployment claims report!

Sources: reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com

JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.